ERD

Periodic Reporting for period 5 - IMMUNOSABR (Clinical proof of concept through a randomised phase II study: a combinati...

Project: IMMUNOSABR

Updated at: 01-11-2024

Show more information

Project acronym IMMUNOSABR

Structural and functional radiomics for lung cancer

Project: IMMUNOSABR

Updated at: 31-03-2024

Show more information

Project acronym IMMUNOSABR

Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiom...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Automated detection and segmentation of non-small cell lung cancer computed tomography images

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Pho...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Multi-Scale Modeling and Oxygen Impact on Tumor Temporal Evolution: Application on Rectal Cancer During Radiotherapy

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter s...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in n...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Im...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Results and adverse events of personalized peptide receptor radionuclide therapy with <sup>90</sup>Yttrium and <sup>177<...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Will immunotherapy really change radiotherapy?

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Informed Consent Form

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogen...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Evidence on the efficacy of primary radiosurgery or stereotactic radiotherapy for drug-resistant non-neoplastic focal ep...

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

The posterior cerebellum, a new organ at risk?

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

How Advances in Imaging Will Affect Precision Radiation Oncology

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Online version of public web site

Project: IMMUNOSABR

Updated at: 31-07-2023

Show more information

Project acronym IMMUNOSABR

Resources

Selected filters:

Periodic Reporting for period 5 - IMMUNOSABR (Clinical proof of concept through a randomised phase II study: a combinati...

Structural and functional radiomics for lung cancer

Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiom...

Automated detection and segmentation of non-small cell lung cancer computed tomography images

Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Pho...

Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription

Multi-Scale Modeling and Oxygen Impact on Tumor Temporal Evolution: Application on Rectal Cancer During Radiotherapy

Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter s...

18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in n...

Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Im...

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV...

Results and adverse events of personalized peptide receptor radionuclide therapy with <sup>90</sup>Yttrium and <sup>177<...

Will immunotherapy really change radiotherapy?

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer

Informed Consent Form

Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogen...

Evidence on the efficacy of primary radiosurgery or stereotactic radiotherapy for drug-resistant non-neoplastic focal ep...

A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy

The posterior cerebellum, a new organ at risk?

How Advances in Imaging Will Affect Precision Radiation Oncology

Online version of public web site